Benedikt Weber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Benedikt Weber has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Johannes Buchner
Center for Functional Protein Assemblies (CPA), Department Bioscience, TUM School of Natural Science, Technical University of Munich, Ernst-Otto-Fischer-Strasse 8, Garching, Germany
5 shared publications - Manuel Hora
Technische Universität München Universitätsbibliothek München Deutschland
3 shared publications Bernd Reif
Center for Integrated Protein Science Munich at the Department Chemie, Technische Universität München, Lichtenbergstr, 4, 85748 Garching, Germany
2 shared publications- Bernd Reif
Technical University of Munich
2 shared publications Carolin Berner
From the Center for Integrated Protein Science Munich, Departments of Chemie and
2 shared publicationsChristine John
Center for Integrated Protein Science Munich at the Department Chemie, Technische Universität München, 85748 Garching, Germany
2 shared publications
Latest Publications
- 1 December 2018
- Published by Elsevier in Journal of Molecular Biology
- Vol. 430 (24) , 4925-4940
The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity
- 1 December 2018
- Published by Elsevier in Journal of Molecular Biology
- Vol. 430 (24) , 4925-4940
The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity
- Open Access
- 1 November 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (44) , 17107-17118
A single residue switch reveals principles of antibody domain integrity
- 1 November 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (44) , 17107-17118
Open AccessA single residue switch reveals principles of antibody domain integrity
- Open Access
- 27 September 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (41) , E8575-E8584
A peptide extension dictates IgM assembly
Significance: How protein assemblies with complex topologies are formed is an important question in structural biology. An intriguing example is IgM, a complex of over 1,200 kDa consisting of six antibody subunits (or five in the presence of the J-chain protein). These are arranged in a ring-like structure connected by disulfide bonds. Here, we show that in vitro and in cell culture, a short peptide extension of the IgM heavy chain is sufficient to steer the formation of the hexameric complex. The formation of a disulfide bond triggers conformational changes in the peptide extensions, which involve specific hydrophobic residues. Our study reveals the redox-controlled assembly of a large protein complex via structural rearrangements in a peptide as a design principle.
- 27 September 2017
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (41) , E8575-E8584
Open AccessA peptide extension dictates IgM assembly
Significance: How protein assemblies with complex topologies are formed is an important question in structural biology. An intriguing example is IgM, a complex of over 1,200 kDa consisting of six antibody subunits (or five in the presence of the J-chain protein). These are arranged in a ring-like structure connected by disulfide bonds. Here, we show that in vitro and in cell culture, a short peptide extension of the IgM heavy chain is sufficient to steer the formation of the hexameric complex. The formation of a disulfide bond triggers conformational changes in the peptide extensions, which involve specific hydrophobic residues. Our study reveals the redox-controlled assembly of a large protein complex via structural rearrangements in a peptide as a design principle.
- Open Access
- 25 September 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-17
Determinants of the assembly and function of antibody variable domains
The antibody Fv module which binds antigen consists of the variable domains VLand VH. These exhibit a conserved ß-sheet structure and comprise highly variable loops (CDRs). Little is known about the contributions of the framework residues and CDRs to their association. We exchanged conserved interface residues as well as CDR loops and tested the effects on two Fvs interacting with moderate affinities (KDs of ~2.5 µM and ~6 µM). While for the rather instable domains, almost all mutations had a negative effect, the more stable domains tolerated a number of mutations of conserved interface residues. Of particular importance for Fv association are VLP44 and VHL45. In general, the exchange of conserved residues in the VL/VHinterface did not have uniform effects on domain stability. Furthermore, the effects on association and antigen binding do not strictly correlate. In addition to the interface, the CDRs modulate the variable domain framework to a significant extent as shown by swap experiments. Our study reveals a complex interplay of domain stability, association and antigen binding including an unexpected strong mutual influence of the domain framework and the CDRs on stability/association on the one side and antigen binding on the other side.
- 25 September 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-17
Open AccessDeterminants of the assembly and function of antibody variable domains
The antibody Fv module which binds antigen consists of the variable domains VLand VH. These exhibit a conserved ß-sheet structure and comprise highly variable loops (CDRs). Little is known about the contributions of the framework residues and CDRs to their association. We exchanged conserved interface residues as well as CDR loops and tested the effects on two Fvs interacting with moderate affinities (KDs of ~2.5 µM and ~6 µM). While for the rather instable domains, almost all mutations had a negative effect, the more stable domains tolerated a number of mutations of conserved interface residues. Of particular importance for Fv association are VLP44 and VHL45. In general, the exchange of conserved residues in the VL/VHinterface did not have uniform effects on domain stability. Furthermore, the effects on association and antigen binding do not strictly correlate. In addition to the interface, the CDRs modulate the variable domain framework to a significant extent as shown by swap experiments. Our study reveals a complex interplay of domain stability, association and antigen binding including an unexpected strong mutual influence of the domain framework and the CDRs on stability/association on the one side and antigen binding on the other side.
- Open Access
- 27 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 41515
Epigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains
Antibody light chain amyloidosis is a rare disease caused by fibril formation of secreted immunoglobulin light chains (LCs). The huge variety of antibody sequences puts a serious challenge to drug discovery. The green tea polyphenol epigallocatechin-3-gallate (EGCG) is known to interfere with fibril formation in general. Here we present solution- and solid-state NMR studies as well as MD simulations to characterise the interaction of EGCG with LC variable domains. We identified two distinct EGCG binding sites, both of which include a proline as an important recognition element. The binding sites were confirmed by site-directed mutagenesis and solid-state NMR analysis. The EGCG-induced protein complexes are unstructured. We propose a general mechanistic model for EGCG binding to a conserved site in LCs. We find that EGCG reacts selectively with amyloidogenic mutants. This makes this compound a promising lead structure, that can handle the immense sequence variability of antibody LCs.
- 27 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 41515
Open AccessEpigallocatechin-3-gallate preferentially induces aggregation of amyloidogenic immunoglobulin light chains
Antibody light chain amyloidosis is a rare disease caused by fibril formation of secreted immunoglobulin light chains (LCs). The huge variety of antibody sequences puts a serious challenge to drug discovery. The green tea polyphenol epigallocatechin-3-gallate (EGCG) is known to interfere with fibril formation in general. Here we present solution- and solid-state NMR studies as well as MD simulations to characterise the interaction of EGCG with LC variable domains. We identified two distinct EGCG binding sites, both of which include a proline as an important recognition element. The binding sites were confirmed by site-directed mutagenesis and solid-state NMR analysis. The EGCG-induced protein complexes are unstructured. We propose a general mechanistic model for EGCG binding to a conserved site in LCs. We find that EGCG reacts selectively with amyloidogenic mutants. This makes this compound a promising lead structure, that can handle the immense sequence variability of antibody LCs.
- Top Cited Papers
- 2 January 2017
- Published by Taylor & Francis in Amyloid
- Vol. 24 (1) , 1-16
ThT 101: a primer on the use of thioflavin T to investigate amyloid formation
Thioflavin T (ThT) has been widely used to investigate amyloid formation since 1989. While concerns have recently been raised about its use as a probe specific for amyloid, ThT still continues to be a very valuable tool for studying kinetic aspects of fibrillation and associated inhibition mechanisms. This review aims to provide a conceptual instruction manual, covering appropriate considerations and pitfalls related to the use of ThT. We start by giving a brief introduction to amyloid formation with focus on the morphology of different aggregate species, followed by a discussion of the quality of protein needed to obtain reliable fibrillation data. After an overview of the photochemical basis for ThT’s amyloid binding properties and artifacts that may arise from this, we describe how to plan and analyze ThT assays. We conclude with recommendations for complementary techniques to address shortcomings in the ThT assay.
- 2 January 2017
- Published by Taylor & Francis in Amyloid
- Vol. 24 (1) , 1-16
Top Cited PapersThT 101: a primer on the use of thioflavin T to investigate amyloid formation
Thioflavin T (ThT) has been widely used to investigate amyloid formation since 1989. While concerns have recently been raised about its use as a probe specific for amyloid, ThT still continues to be a very valuable tool for studying kinetic aspects of fibrillation and associated inhibition mechanisms. This review aims to provide a conceptual instruction manual, covering appropriate considerations and pitfalls related to the use of ThT. We start by giving a brief introduction to amyloid formation with focus on the morphology of different aggregate species, followed by a discussion of the quality of protein needed to obtain reliable fibrillation data. After an overview of the photochemical basis for ThT’s amyloid binding properties and artifacts that may arise from this, we describe how to plan and analyze ThT assays. We conclude with recommendations for complementary techniques to address shortcomings in the ThT assay.
- 26 December 2016
- Published by Taylor & Francis in Amyloid
- Vol. 24 (sup1) , 1
Solid- and solution-state nuclear magnetic resonance spectroscopic studies on antibody light chain amyloid formation and interactions with epigallocatechin gallate
- 26 December 2016
- Published by Taylor & Francis in Amyloid
- Vol. 24 (sup1) , 1
Solid- and solution-state nuclear magnetic resonance spectroscopic studies on antibody light chain amyloid formation and interactions with epigallocatechin gallate